SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge📊Experiments🤖Agents🚦Status📑Docs
Info
ℹVision⭐Showcase📽Demo
📖

Ferroptosis Validation in Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-experiments-ferroptosis-parkinsons
Related Entities
experiments-ferroptosis-parkinsons
Metadata
slugexperiments-ferroptosis-parkinsons
entity_typeexperiment
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (409)
derives_from🧫Ferroptosis Validation in Parkinson's Disease95%
mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design70%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Ferroptosis Validation in Parkinson's Disease70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design70%
see_also🧪Extracellular Matrix Stiffness Modulation70%
see_also🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro70%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading60%
mentions🧫Ferroptosis Validation in Parkinson's Disease60%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
see_also📖acc-chronic-pain60%
see_also📖entities-oligodendrocytes60%
see_also📖ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Member 460%
see_also📖BAP1 (BRCA1-Associated Protein 1)60%
see_also📖DHODH — Dihydroorotate Dehydrogenase60%
see_also📖DLK1 Gene60%
see_also📖DnaJ Heat Shock Protein Family (Hsp40) Member A160%
see_also📖GADD45B — Growth Arrest and DNA Damage Inducible Beta60%
see_also📖got160%
see_also📖GPT - Alanine Transaminase (ALT)60%
see_also📖HDAC5 Gene60%
see_also📖IREB2 — Iron Responsive Element Binding Protein 260%
see_also📖JNK3 (MAPK10)60%
see_also📖kdm1a60%
see_also📖KIF4A — Kinesin Family Member 4A60%
see_also📖LGMN Gene60%
see_also📖MANF Gene60%
see_also📖MAPK10 Gene60%
see_also📖MMP3 Gene60%
see_also📖NOX1 Gene60%
see_also📖NR4A1 Gene60%
see_also📖PGC1A Gene60%
see_also📖PPT1 Gene - Palmitoyl-Protein Thioesterase 160%
see_also📖rab5c60%
see_also📖RAD5160%
see_also📖SFN Gene60%
see_also📖STAT4 Gene60%
see_also📖stim160%
see_also📖TXN — Thioredoxin60%
see_also📖UBE2N60%
see_also📖VKORC1L1 Gene - Vitamin K Epoxide Reductase Complex Subunit 60%
see_also📖WIPI4 Gene60%
see_also📖YAP1 — Yes-Associated Protein 160%
see_also📖ZDHHC8 — Zinc Finger DHHC-Type Palmitoyltransferase 860%
see_also📖Chaperone-Mediated Autophagy in Neurodegeneration60%
see_also📖HDAC5 (Histone Deacetylase 5) Protein60%
see_also📖TRIM28 (KAP1) Protein60%
see_also📖Iron-Laden Microglia60%
see_also📖Iron Dyshomeostasis in MSA Pathogenesis Experiment60%
see_also📖FSP1 Gene - Ferroptosis Suppressor Protein 160%
see_also📖GCLM — Glutamate-Cysteine Ligase Modifier Subunit60%
see_also📖kdm5a60%
see_also📖NQO2 Gene60%
see_also📖OGT — O-GlcNAc Transferase60%
see_also📖PLG — Plasminogen60%
see_also📖PPP1CB Gene60%
see_also📖PRDX1 Gene60%
see_also📖prkaca Gene60%
see_also📖TNFRSF21 Gene60%
see_also📖TYRO3 - TYRO3 Receptor Tyrosine Kinase60%
see_also📖Autoimmune Hypothesis in Alzheimer's Disease60%
see_also📖iron-calcium-glymphatic-convergence-alzheimers60%
see_also📖Iron Chelation Therapy for Neurodegeneration60%
see_also📖Chaperone-Mediated Autophagy in Neurodegeneration60%
see_also📖Iron Accumulation in 4R-Tauopathies: Cross-Disease Compariso60%
see_also📖Iron Accumulation in Progressive Supranuclear Palsy60%
see_also📖Iron Dysregulation in Neurodegeneration60%
see_also📖Iron Homeostasis Dysregulation in Neurodegeneration60%
see_also📖Iron Homeostasis in Neurodegeneration60%
see_also📖iron-metabolism-neurodegeneration60%
see_also📖Lipophagy Pathway in Neurodegeneration60%
see_also📖FSP1/AIFM2 (Ferroptosis Suppressor Protein 1)60%
see_also📖PRDX1 Protein (Peroxiredoxin 1)60%
see_also📖Iron Chelation Therapy60%
see_also📖iron-chelation-therapy-parkinsons60%
see_also📖iron-chelation-therapy-parkinsons-disease60%
see_also📖Iron Chelators in Neurodegenerative Disease60%
see_also📖FLT1 Gene60%
see_also📖SLC11A160%
see_also📖ATG2A60%
see_also📖PSMB860%
see_also📖Lipid Peroxidation in Neurodegeneration60%
see_also📖Adaptive Immunity in Neurodegeneration: Investment Landscape60%
see_also📖Adaptive Immunity in Neurodegeneration60%
see_also📖IDO1 — Indoleamine 2,3-Dioxygenase 160%
see_also📖DNAJC12 Gene60%
see_also📖FTL Gene60%
see_also📖GAA Gene60%
see_also📖NFATc1 — Nuclear Factor of Activated T Cells 160%
see_also📖NOX2 Gene60%
see_also📖NQO1 — NAD(P)H Quinone Dehydrogenase 160%
see_also📖PRKCQ60%
see_also📖PRMT560%
see_also📖SLC7A1 Gene60%
see_also📖USP7 Gene60%
see_also📖Glutathione Metabolism Pathway60%
see_also📖Kynurenine Pathway Dysregulation in 4R-Tauopathies60%
see_also📖Ferritin Light Chain (FTL)60%
see_also📖NOX2/CYBB (NADPH Oxidase 2)60%
see_also📖NQO1 Protein (NAD(P)H Quinone Dehydrogenase 1)60%
see_also📖deferiprone-neurodegeneration60%
see_also📖Kynurenine Pathway Modulators for Neurodegeneration60%
see_also📖NF2 — Merlin/Neurofibromin 260%
see_also📖Traumatic Brain Injury and Alzheimer's Disease Relation60%
see_also📖Basal Radial Glia60%
see_also📖Bergmann Glia60%
see_also📖enteric-glia60%
see_also📖Muller Glia60%
see_also📖Neural Crest-Derived Glia60%
see_also📖NG2 Glia (Oligodendrocyte Precursor Cells)60%
see_also📖Nigral Glia in Parkinson's Disease60%
see_also📖Outer Radial Glia60%
see_also📖Radial Glia60%
see_also📖Satellite Glial Cells (PNS)60%
see_also📖pck260%
see_also📖ABCA7 (Redirect)60%
see_also📖TXN2 — Thioredoxin 260%
see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%
see_also📖GLS - Glutaminase60%
see_also📖OTUD5 Gene60%
see_also📖OTULIN — OTU Deubiquitinase with Linear Linkage Specificity60%
see_also📖SHARPIN — SHANK Associated RH Domain Interactor60%
see_also📖SLC39A860%
see_also📖UBR5 - Ubiquitin-Protein Ligase E3 Component N-Recognin 560%
see_also📖Lipid Peroxidation in Neurodegeneration60%
see_also📖KIF20A — Kinesin Family Member 20A60%
see_also📖PRKCI60%
related🧪Circadian-Gated Maresin Biosynthesis Amplification55%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%
related🧪Mitochondrial SPM Synthesis Platform Engineering55%
related🧪Senescence-Induced Lipid Peroxidation Spreading54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🧫S-equol-induced ferroptosis mechanism in TNBC cells50%
mentions🧫Gandouling protection against brain injury in Wilson's 50%
mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%
mentions🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective50%
mentions🧪VCP-Mediated Autophagy Enhancement50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪Multi-Modal Stress Response Harmonization50%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches50%
mentions🧪Axonal RNA Transport Reconstitution50%
mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%
mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪Senescence-Associated Myelin Lipid Remodeling50%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🧫Proposed experiment from debate on Microglia activate astroc50%
related🧫Proposed experiment from debate on Microglia activate astroc50%
related🔬Gene expression changes in aging mouse brain predicting neur50%
related🔬Gene expression changes in aging mouse brain predicting neur50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
mentions🧪Extracellular Matrix Stiffness Modulation40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli40%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪Mitochondrial SPM Synthesis Platform Engineering40%
related🧪VCP-Mediated Autophagy Enhancement40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪Multi-Modal Stress Response Harmonization40%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪Lipid Droplet Dynamics as Phenotype Switches40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Circadian-Gated Maresin Biosynthesis Amplification40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%
related🧪HDAC3-Selective Inhibition for Clock Reset40%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Transcriptional Autophagy-Lysosome Coupling40%
related🧪Senescence-Associated Myelin Lipid Remodeling40%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%
related🧪Senescence-Induced Lipid Peroxidation Spreading40%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%
related🧪Senescence-Activated NAD+ Depletion Rescue40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬What are the mechanisms underlying selective vulnerability o35%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%
mentions🔬What are the mechanisms underlying blood-brain barrier trans35%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross35%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa35%
mentions🔬What are the mechanisms underlying digital biomarkers and ai35%
mentions🔬What are the mechanisms underlying senolytic therapy for age35%
mentions🔬What are the mechanisms underlying neuroinflammation resolut35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 35%
mentions🔬What are the mechanisms underlying rna binding protein dysre35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%
mentions🔬What are the mechanisms underlying perivascular spaces and g35%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬Investigate prion-like spreading of tau pathology through co35%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub